Director of Science Policy for Europe,
Adam is Pfizer’s Director of Science Policy for Europe and works closely with the company’s R&D organisation to support European and global projects on orphan drugs and rare diseases, R&D productivity, collaborative research, stem cell science and personalised medicine.
Adam has been a member of the EuropaBio/EBE joint task force on rare diseases and orphan medicinal products since 2007 where he is the topic lead on rare diseases R&D. Adam has also supported Pfizer’s R&D leadership in their work at the EFPIA research directors group (RDG). Before joining Pfizer seven years ago, Adam worked for a variety of government and public sector organisations, including the Prime Minister’s Strategy Unit – on GM crops and innovation policy; the House of Lords Science and Technology Committee – on topics from complementary medicine to human genetic databases; and the Commission for Patient and Public Involvement in Health – bringing the views of local people and voluntary organisations to health service decision-makers. Adam also spent three years as a post-doctoral researcher at the Rutherford Appleton Laboratory, Oxfordshire. He has a PhD in chemistry.